AU2015901160A0 - Immunomodulatory peptides and methods of use - Google Patents

Immunomodulatory peptides and methods of use

Info

Publication number
AU2015901160A0
AU2015901160A0 AU2015901160A AU2015901160A AU2015901160A0 AU 2015901160 A0 AU2015901160 A0 AU 2015901160A0 AU 2015901160 A AU2015901160 A AU 2015901160A AU 2015901160 A AU2015901160 A AU 2015901160A AU 2015901160 A0 AU2015901160 A0 AU 2015901160A0
Authority
AU
Australia
Prior art keywords
methods
immunomodulatory peptides
immunomodulatory
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2015901160A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
QIMR Berghofer Medical Research Institute
Original Assignee
Queensland Institute of Medical Research QIMR
Filing date
Publication date
Application filed by Queensland Institute of Medical Research QIMR filed Critical Queensland Institute of Medical Research QIMR
Publication of AU2015901160A0 publication Critical patent/AU2015901160A0/en
Abandoned legal-status Critical Current

Links

AU2015901160A 2015-03-31 Immunomodulatory peptides and methods of use Abandoned AU2015901160A0 (en)

Publications (1)

Publication Number Publication Date
AU2015901160A0 true AU2015901160A0 (en) 2015-04-16

Family

ID=

Similar Documents

Publication Publication Date Title
IL262366A (en) Cd80 variant immunomodulatory proteins and uses thereof
EP3416634A4 (en) Immunomodulatory agents and methods of use thereof
EP3436048A4 (en) Neoantigens and methods of their use
EP3383430A4 (en) Antibodies and methods of use thereof
EP3245291A4 (en) Novel micro-dystrophins and related methods of use
EP3509615A4 (en) Stable peptides and methods of use thereof
EP3280441A4 (en) Anti-sortilin antibodies and methods of use thereof
EP3303435A4 (en) Hydrofluoroolefins and methods of using same
EP3092001A4 (en) Immunomodulatory compositions and methods of use thereof
EP3177638A4 (en) Targeting peptides and methods of use
EP3394098A4 (en) Anti-myostatin antibodies and methods of use
EP3455322A4 (en) Hydrofluoroolefins and methods of using same
EP3341017A4 (en) Immunomodulatory compositions and methods of use thereof
EP3303436A4 (en) Hydrofluoroolefins and methods of using same
EP3274472A4 (en) Antimicrobial peptides and methods of use thereof
EP3349851A4 (en) Light-responsive polypeptides and methods of use thereof
EP3389705A4 (en) Listeria-based immunotherapy and methods of use thereof
EP3152236A4 (en) Method for decreasing immunogenicity of protein and peptide
EP3265476A4 (en) Protoxin-ii variants and methods of use
EP3270918A4 (en) Anti-met antibodies and methods of use thereof
EP3215172A4 (en) Modifications and uses of conotoxin peptides
EP3635000A4 (en) Manabodies and methods of using
EP3277304A4 (en) Protoxin-ii variants and methods of use
EP3277727A4 (en) Tnfrsf14/ hvem proteins and methods of use thereof
EP3288379A4 (en) Peptide compositions and methods of use